Azenta (AZTA) Income from Continuing Operations (2010 - 2026)
Azenta (AZTA) posted quarterly Income from Continuing Operations of 162204000.0 for Q1 2026, down 721.41% year-over-year from 26102537.59 in Q1 2025, and down 3025.32% quarter-over-quarter from 5190000.0 in Q4 2025.
Azenta (AZTA) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Income from Continuing Operations for 17 consecutive years, with 162204000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 721.41% year-over-year to 162204000.0; the TTM figure through Mar 2026 stood at 187473000.0 (down 552.74% YoY), while the FY2025 annual figure was 15190000.0, changed N/A from the prior year.
- Income from Continuing Operations declined to 162204000.0 in Q1 2026 per AZTA's latest filing, from 5190000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 4200000.0 in Q3 2025 and bottomed at 162204000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 15184411.76 across 5 years, with a median of 5190000.0 in 2025.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations tumbled 741.84% — and 2025, when it surged 340.69%.
- Azenta's Income from Continuing Operations stood at 11235000.0 in 2022, then surged by 49.0% to 5730000.0 in 2023, then slipped by 23.89% to 7099000.0 in 2024, then climbed by 26.89% to 5190000.0 in 2025, then plunged by 3025.32% to 162204000.0 in 2026.
- Business Quant data shows AZTA's Income from Continuing Operations at 162204000.0 in Q1 2026, 5190000.0 in Q4 2025, and 4200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | -163.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -163.76 Mn |
| Mar 31, 2026 | -162.20 Mn |
| Dec 31, 2025 | -5.19 Mn |
| Sep 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | -332,000.00 |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -7.10 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -130,000.00 |
| Mar 31, 2024 | -16.76 Mn |
| Dec 31, 2023 | -5.73 Mn |
| Sep 30, 2023 | -14.49 Mn |
| Jun 30, 2023 | -2.47 Mn |
| Mar 31, 2023 | -1.99 Mn |
| Dec 31, 2022 | -11.24 Mn |
| Sep 30, 2022 | -4.37 Mn |
| Jun 30, 2022 | -7.02 Mn |
| Mar 31, 2022 | -1.82 Mn |
| Dec 31, 2021 | 2.88 Mn |
| Sep 30, 2021 | -22.38 Mn |